Armata Pharmaceuticals Announces First Patient Dosed in the Phase 2a Portion of the Phase 1b/2a ‘diSArm’ Study of AP-SA02 in Adults with Bacteremia Due to Staphylococcus aureus

/in ,

Initiation of the Phase 2a portion follows DRC review of positive safety and tolerability data from recently completed Phase 1b portion Study being conducted in partnership with the U.S. Department of Defense LOS ANGELES, /Link Here/ — Armata Pharmaceuticals, Inc. (NYSE American: ARMP) (“Armata” or the “Company”), a biotechnology company focused on pathogen-specific bacteriophage therapeutics for antibiotic-resistant and […]

Read more

CalciMedica Announces Upcoming Presentations and Events in September

/in

LA JOLLA, Calif., Sept. 6, 2023 /Link here/ — CalciMedica Inc. (“CalciMedica”) (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today announced that Rachel Leheny, Ph.D., Chief Executive Officer, will participate in a presentation at the H.C. Wainwright 25th […]

Read more

CalciMedica to Host Acute Pancreatitis Clinical Experts Event on September 21, 2023

/in

LA JOLLA, Calif., Aug. 31, 2023 /PRNewswire/ Link here — CalciMedica Inc. (“CalciMedica”) (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today announced that it will host a virtual clinical experts event on Thursday, September 21, 2023, from 10:30 […]

Read more

Canary Medical Wins “Healthcare Analytics Innovation Award” in 7th Annual MedTech Breakthrough Award Program

/in

Prestigious International Annual Awards Program Recognizes Standout Digital Health & Medical Technology Products and Companies May 03, 2023 08:30 ET| Source: Canary Medical, a medical data company focused on the development and commercialization of its patented implantable sensor technology and complementary data and analytics ecosystem, today announced that it has been selected as the winner of the […]

Read more

SHAREHOLDER UPDATE: ADHERIUM ENTERS RAPID US COMMERCIALISATION PHASE

/in

Melbourne, Australia; Link here – 27 July 2023: Adherium Limited (ASX: ADR), a leading provider of respiratory eHealth, remote monitoring and data management solutions, today announced it is entering a rapid commercialisation phase in reimbursed remote patient monitoring in the globally significant US market. Adherium’s leading position in remote patient monitoring, using the Hailie® app […]

Read more

Canary Medical Wins “Healthcare Analytics Innovation Award” in 7th Annual MedTech Breakthrough Award Program

/in

Prestigious International Annual Awards Program Recognizes Standout Digital Health & Medical Technology Products and Companies VANCOUVER, British Columbia; Link here – May 3, 2023 – Canary Medical, a medical data company focused on the development and commercialization of its patented implantable sensor technology and complementary data and analytics ecosystem, today announced that it has been […]

Read more

CalciMedica Expands Executive Team with New Appointments

/in

Raven Jaeger, M.S. named Chief Regulatory Officer and Andrew Cunningham, M.D., MRCPI, named Senior Vice President, Clinical Development LA JOLLA, Calif., May 23, 2023 (GLOBE NEWSWIRE) — Link here: CalciMedica Inc. (“CalciMedica”) (OTCQB: CALC), a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need, today announced the appointments of […]

Read more

Parkinson’s patients benefit from revolutionary watch on the NHS to manage care at home

/in

Patients with Parkinson’s disease are being given life-changing smart watches that allow doctors to remotely assess their condition in a pioneering project to revolutionise NHS care. NHS chief executive Amanda Pritchard said: “Parkinson’s is an incurable illness that has a significant impact on peoples’ lives and this small watch will dramatically improve their quality of life […]

Read more

Adherium’s UK Partner awarded place on prestigious NHS Innovation Accelerator for Hailie Digital Inhaler

/in

Link here: Adherium Limited is pleased to announce that its UK value-add distribution partner, Helicon  Health Ltd, has been awarded a prestigious 3 year Fellowship on the 2023 NHS Innovation Accelerator (NIA), to boost their new Director of Operations, Sander Ten Veldhuijs, in scaling the Hailie® Digital Inhaler solution across NHS England. The NIA programme […]

Read more

Saluda Medical Announces $150M Equity Financing Led by Wellington Management with Fidelity Management & Research Company and TPG

/in

Financing Further Propels Commercial and Research & Development Initiatives Artarmon, NSW & Bloomington, MN – April 13, 2023, Link here – Saluda Medical Inc. (“Saluda Medical”), a global medical device company revolutionizing the field of neuromodulation with an emerging portfolio of therapies driven by advanced closed-loop technologies designed to treat debilitating neurological disorders, today announced the […]

Read more